France· FR:66417119
METHERGIN 0,20 mg/1 ml, solution injectable, ampoule
A methylergometrine product containing maléate de méthylergométrine, registered in France by ESSENTIAL PHARMA (M) (MALTE), on the national reimbursement list. The same ATC class is registered in 11 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Methylergometrine is registered in 11 of 19 countries.
Countries holding a registration under ATC G02AB01 (methylergometrine), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 8 of them publish a price we can compare per daily dose
Methylergometrine · ATC G02AB01
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Icelandprice
- Italyprice
- Netherlands
- Norwayprice
- Switzerlandprice
Price per daily dose
What a daily dose of methylergometrine costs, country by country.
Normalised to the WHO defined daily dose (0.2 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Methylergometrine · price per daily dose (0.2 mg)
USD · FX 28 Sept 2026
- IT Italy$0.19
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- MALÉATE DE MÉTHYLERGOMÉTRINE
- Manufacturer
- ESSENTIAL PHARMA (M) (MALTE)
- Country
- France (FR)
- ATC code
- G02AB01
- ATC class
- Methylergometrine
- Defined daily dose
- 0.2 mg, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
1 priced- cip1334009306696243 ampoule(s) en verre de 1 mlEUR 2.15
- cip13340095621971110 ampoule(s) en verre de 1 ml
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
138 interactions on record for methylergometrine.
Graded by severity as the source publishes them — 43 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Methylergometrine · interactions on record
138 records
- 43 severe
- 90 moderate
- 5 info
Most severe, free to view
- EpinephrineA01AD01severe
- IsomethepteneA03AX10severe
- LorcaserinA08AA11severe
- PhenylpropanolaminA08AA13severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Methylergometrine in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsMethergin, oplossing voor injectie 0,2 mg/mlEssential Pharma Limited
- United StatesMethergineLupin Pharmaceuticals,Inc.
- GermanyMetherginEssential Pharma Limited
- NorwayMetherginNovartis
- ItalyMETHERGIN*15 cpr rivestite 0,125 mgESSENTIAL PHARMA (M) LTD
- SpainMETHERGIN 0,125 MG COMPRIMIDOS RECUBIERTOSEssential Pharma Limited
- FinlandMetherginNovartis Pharma AG
- IcelandMetherginEssential Pharma Limited
Authorised across Europe · EMA
The same active substance is authorised in 11 EEA countries. Names it is sold under:
- Belgium · Methergin
- Bulgaria · Methergin, Метергин
- Germany · Methergin, Methergin®
- Denmark · Methergin
- Spain · Methergin, Methergín
- Greece · Demergin
- Iceland · Methergin
- Italy · Methergin
- Luxembourg · Methergin
- Netherlands · Methergin
- Sweden · Methergin
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/5cdd7cee-efe7-4e32-b2b7-3e8bd9e9784d GET /v1/drugs/5cdd7cee-efe7-4e32-b2b7-3e8bd9e9784d?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "66417119",
"date_amm": "1995-07-11",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "MALÉATE DE MÉTHYLERGOMÉTRINE",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "solution injectable",
"voies_administration": "intramusculaire;intraveineuse",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about methylergometrine.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.